Camille completed her bachelor and master’s degrees in Biomedical Sciences in Translational Research at Université Libre de Bruxelles, Belgium. During her master’s thesis, she studied the impact of m6A modification in the viral fitness of group B coxsackieviruses at the ULB Center for Diabetes Research. She joined Guy Sauvageau’s lab in January 2023 to work on identification of novel agents for targeted therapies in acute myeloid leukemia.